









Markets
/
Stocks
/
nasdaq-lnth
/

Lantheus Holdings Inc

LNTH

View Detailed Chart

74.410USD

-6.850-8.43%

Close 07/16, 16:00（ET）Quotes delayed by 15 min

5.15BMarket Cap

20.23P/E TTM



Lantheus Holdings Inc

74.410

-6.850-8.43%

Overview Company Financials

Financials

Intraday

30m

Today

-8.43%

5 Days

-10.88%

1 Month

-4.38%

6 Months

-18.75%

Year to Date

-16.82%

1 Year

-37.10%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 13 analysts

BUY

Current Rating

128.308

Target Price

57.90%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

114

Total

Median

Average

Company name

Ratings

Analysts

Lantheus Holdings Inc

LNTH

Medtronic PLC

MDT

Stryker Corp

SYK

Zimmer Biomet Holdings Inc

ZBH

Abbott Laboratories

ABT

Dexcom Inc

DXCM

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(10)

Neutral(1)

Buy(0)

Indicators

Sell(4)

Neutral(1)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.365

Sell

RSI(14)

35.512

Neutral

STOCH(KDJ)(9,3,3)

42.195

Sell

ATR(14)

3.152

High Vlolatility

CCI(14)

-275.646

Oversold

Williams %R

67.326

Sell

TRIX(12,20)

0.083

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

80.774

Sell

MA10

80.900

Sell

MA20

80.546

Sell

MA50

80.421

Sell

MA100

89.583

Sell

MA200

92.500

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Lantheus Holdings, Inc. is a radiopharmaceutical-focused company engaged in delivering science to enable clinicians to find, fight and follow diseases to deliver patient outcomes. It classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Radiopharmaceutical Oncology diagnostics and therapeutics help healthcare professionals (HCPs) find, fight and follow cancer, with a focus on prostate cancer. Precision Diagnostic products assist HCPs to find and follow diseases, with a focus on cardiology. Strategic Partnerships focus on enabling precision medicine through the use of biomarker solutions, digital solutions, and radiotherapeutic platforms. Its commercial products include PYLARIFY, DEFINITY, TechneLite, and others. Its clinical candidates include LNTH-2404, NAV-4694, and PNT2002, others. Its OCTEVY is a registrational-stage positron emission tomography (PET) diagnostic imaging agent targeting neuroendocrine tumors.

Ticker SymbolLNTH

CompanyLantheus Holdings Inc

CEOMr. Brian A. Markison

Websitehttps://www.lantheus.com/